FAP and cancer: In cancer patients that high FAP expression in CAFs restricts T cell distribution and promotes immune checkpoint blockades (ICBs) resistance (41, 157, 158), treatment with FAP inhibitor could neutralize the immunosuppressive function of CAFs and reverse anti-PD1 drug resistance.